Pannie Trifillis

Pannie Trifillis, PhD, is a seasoned biopharma executive with 25 years of experience in the discovery, development, and commercialization of therapies for rare genetic diseases. Currently serving as Senior Vice President of Medical Affairs and Scientific Communications at Rapid Commercialization Partners, Pannie leverages extensive expertise in medical affairs omnichannel strategy, KOL engagement, and real-world evidence generation. Pannie co-founded Precision Science Consulting, LLC, providing specialized consulting services across diverse therapeutic areas, particularly focusing on rare genetic diseases. Previously, Pannie held various leadership roles at PTC Therapeutics, Inc., significantly contributing to the global launch and market expansion of therapies for Duchenne Muscular Dystrophy (DMD). Pannie's academic background includes a PhD in Molecular Biology and Human Genetics from the University of Pennsylvania and a BA in Biology and Chemistry from Wellesley College.